Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

ARTIVION, INC.

AORT

CIK 0000784199 Β· Quarterly mode Β· latest period FY2025 (Q4) (ending 2025-12-31) Β· sourced from SEC EDGAR

At a glance Β· FY2025 (Q4)

Revenue
$116M
↑+19.2% +$19Mvs FY2024 (Q4)
Operating Income
$11M
↑+300.1% +$8Mvs FY2024 (Q4)
Net Income
$2M
Gross Profit
$73M
↑+18.9% +$12Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot Β· latest annual filed values Β· S&P 500 calibration

Average
48/100
  • Profitability
    0ROIC 3.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.53 (above 1.5 = solid)
  • Leverage
    76D/E 0.48 (under 0.5 = conservative)
  • Efficiency
    24Asset Turnover 0.51x (1.0+ = capital-efficient)
  • Growth
    81Revenue YoY +19.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    8Op Margin 9.2% Β· trend -2.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project AORT's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$0.31
Total enterprise IV
$14M
Diluted shares
0.05B
Terminal PV
$10M (72% of total)
Year-5 FCF
$1M
YearProjected FCFDiscounted PV
+1$906K$824K
+2$979K$809K
+3$1M$794K
+4$1M$780K
+5$1M$765K
Terminal$17M$10M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$39M
investment in PP&E
Dividends paid (TTM)
β€”
cash returned to holders
Stock buybacks (TTM)
β€”
share count reduction
Stock-based comp (TTM)
$24M
non-cash dilution

Balance sheet Β· 2025-12-31

latest filed snapshot
Total assets
$885M
everything owned
Total liabilities
$437M
everything owed
Stockholders' equity
$448M
shareholder claim
Net debt
$150M
LT debt minus cash

Recent performance Β· 64 quarters

Revenue↑+19.2% +$19M
$116M
Net Income
$2M
Free Cash Flow↓-191.2% -$17M
$-8M
Operating Margin↑+6.5pts
9.2%

Drill down